These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3197744)

  • 21. Differences in oral verapamil absorption as a function of time of day.
    Eldon MA; Battle MM; Voigtman RE; Colburn WA
    J Clin Pharmacol; 1989 Nov; 29(11):989-93. PubMed ID: 2600194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of verapamil on the pharmacokinetics of adriamycin.
    Kerr DJ; Graham J; Cummings J; Morrison JG; Thompson GG; Brodie MJ; Kaye SB
    Cancer Chemother Pharmacol; 1986; 18(3):239-42. PubMed ID: 3026675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced bioavailability of verapamil after oral administration with hesperidin in rats.
    Piao YJ; Choi JS
    Arch Pharm Res; 2008 Apr; 31(4):518-22. PubMed ID: 18449511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulatory effects of intravenous and oral atenolol in acute myocardial infarction.
    Midtbø K; Silke B; Verma SP; Reynolds GW; Hafizullah M; Taylor SH
    Angiology; 1988 Sep; 39(9):795-801. PubMed ID: 3421513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.
    Brown HC; Carruthers SG; Johnston GD; Kelly JG; McAinsh J; McDevitt DG; Shanks RG
    Clin Pharmacol Ther; 1976 Nov; 20(5):524-34. PubMed ID: 10125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects.
    Murdoch DL; Thomson GD; Thompson GG; Murray GD; Brodie MJ; McInnes GT
    Br J Clin Pharmacol; 1991 Mar; 31(3):323-32. PubMed ID: 2054272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic interactions of the oral renin inhibitor aliskiren with lovastatin, atenolol, celecoxib and cimetidine.
    Dieterle W; Corynen S; Vaidyanathan S; Mann J
    Int J Clin Pharmacol Ther; 2005 Nov; 43(11):527-35. PubMed ID: 16300168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of three different oral doses of verapamil on the disposition of theophylline.
    Stringer KA; Mallet J; Clarke M; Lindenfeld JA
    Eur J Clin Pharmacol; 1992; 43(1):35-8. PubMed ID: 1505606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced verapamil clearance during long-term oral administration.
    Shand DG; Hammill SC; Aanonsen L; Pritchett EL
    Clin Pharmacol Ther; 1981 Nov; 30(5):701-6. PubMed ID: 7297027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous first-order and capacity-limited elimination kinetics after oral administration of verapamil.
    Gupta SK; Hwang S; Atkinson L; Longstreth J
    J Clin Pharmacol; 1996 Jan; 36(1):25-34. PubMed ID: 8932540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verapamil metabolite exposure in older and younger men during steady-state oral verapamil administration.
    Abernethy DR; Wainer IW; Anacleto AI
    Drug Metab Dispos; 2000 Jul; 28(7):760-5. PubMed ID: 10859149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central nervous system kinetics of atenolol and metoprolol in the dog during long term treatment.
    Abrahamsson T; Lignell E; Mikulski A; Olovson SG; Regårdh CG
    Drug Metab Dispos; 1989; 17(1):82-6. PubMed ID: 2566475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absorption pharmacokinetics of atenolol in patients with the Marfan syndrome.
    Phelps SJ; Alpert BS; Ward JL; Pieper JA; Lima JJ
    J Clin Pharmacol; 1995 Mar; 35(3):268-74. PubMed ID: 7608315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of naringin on the pharmacokinetics of verapamil and one of its metabolites, norverapamil, in rabbits.
    Kim HJ; Choi JS
    Biopharm Drug Dispos; 2005 Oct; 26(7):295-300. PubMed ID: 16013069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiological disposition of verapamil in man.
    Schomerus M; Spiegelhalder B; Stieren B; Eichelbaum M
    Cardiovasc Res; 1976 Sep; 10(5):605-12. PubMed ID: 971476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation by dietary salt of verapamil disposition in humans.
    Darbar D; Fromm MF; Dell'Orto S; Kim RB; Kroemer HK; Eichelbaum M; Roden DM
    Circulation; 1998 Dec; 98(24):2702-8. PubMed ID: 9851956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of verapamil and its metabolite norverapamil in rats with hyperlipidaemia induced by poloxamer 407.
    Lee YS; Yoon JN; Yoon IS; Lee MG; Kang HE
    Xenobiotica; 2012 Aug; 42(8):766-74. PubMed ID: 22300394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol.
    Czendlik CH; Sioufi A; Preiswerk G; Howald H
    Eur J Clin Pharmacol; 1997; 52(6):451-9. PubMed ID: 9342580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single dose pharmacokinetics of (S)-atenolol administered orally as a single enantiomer formulation and as a racemic mixture (Tenormin).
    Clementi WA; Garvey TQ; Clifton GD; McCoy RA; Brandt S; Schwartz S
    Chirality; 1994; 6(3):169-74. PubMed ID: 8024947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioequivalence of two tablet formulations of atenolol after single oral administration in healthy volunteers.
    Niopas I; Daftsios AC; Xanthakis I; Nikolaidis N; Njau SN
    Arzneimittelforschung; 2000 Mar; 50(3):243-7. PubMed ID: 10758775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.